Use of anakinra in treatment of combination of calcium pyrophosphate deposition desease and gout (clinical observation)-Reference-Cited by-同舟云学术

Use of anakinra in treatment of combination of calcium pyrophosphate deposition desease and gout (clinical observation)

Published:2022-07-25 Issue:15 Volume: Page:14-19
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Eliseev M. S.¹^ORCID,Cheryomushkina E. V.¹^ORCID,Krasnenko S. O.¹^ORCID,Aristova M. V.¹

Affiliation:

1. V. A. Nasonova Research Institute of Rheumatology

Abstract

Gout and calcium pyrophosphate crystal deposition disease (CPPD) are the most common inflammatory rheumatic diseases. It is known that the clinical manifestations of both diseases can simulate each other, in addition, cases of a combination of gout and CPPD are not uncommon, which complicates the diagnosis and selection of therapy. We present a case report of the successful use of the interleukin-1 beta (IL-1β) receptor antagonist Anakinra in a patient with a combination of gout and CPPD with chronic arthritis resistant to previous therapy with colchicine, non-steroidal anti-inflammatory drugs and glucocorticoids.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference41 articles.

1. Doaré E., Robin F., Racapé H., et al. Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study. Rheumatol Ther. 2021; 8 (3): 1241–1253. DOI: 10.1007/s40744–021–00335–7.

2. Eliseev M. S., Zhelyabina O. V. The combination of gout and calcium pyrophosphate deposition disease: the difficulties of diagnosis and treatment. RMJ. Medical Review. 2017. No. 1. P. 44–47.

3. Ramonda R., Frallonardo P., Oliviero F.., Lorenzin MG., Ortolan A., Scanu A., Punzi L. Pain and microcrystalline arthritis. Reumatismo. 2014 Jun 6; 66 (1): 48–56. DOI: 10.4081/reumatismo.2014.765. PMID: 24938197.

4. Singh J. A., Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020 Jun; 50 (3S): S 11–S 16. DOI: 10.1016/j.semarthrit.2020.04.008. PMID: 32620196.

5. Abhishek A., Doherty M. Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy. Rheum Dis Clin North Am. 2014 May; 40 (2): 177–91. DOI: 10.1016/j.rdc.2014.01.002. Epub 2014 Feb 20. PMID: 24703342.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resolution of the Council of Excperts (16th June, 2022): Therapy of gouty arthritis with an IL-1 inhibitor (anakinra);Rheumatology Science and Practice;2022-12-26